Singapore markets closed

Straits Times Index
3,325.65
-0.63(-0.02%)
S&P 500
5,469.30
+21.43(+0.39%)
Dow
39,112.16
-299.05(-0.76%)
Nasdaq
17,717.65
+220.84(+1.26%)
Bitcoin USD
61,449.88
+620.89(+1.02%)
CMC Crypto 200
1,276.91
-6.88(-0.54%)

GERN Jul 2024 5.500 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.0500

-0.0200

(-28.57%)

As of 03:44PM EDT. Market open.

Loading interactive chart…

Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FOSTER CITY, Calif., June 20, 2024--Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase an aggregate of 222,660 shares of Geron common stock as inducements to newly hired employees in connection with commencement of employment with the Company.
Simply Wall St.
Geron Corporation's (NASDAQ:GERN) large institutional owners must be happy as stock continues to impress, up 27% over the past week
Key Insights Institutions' substantial holdings in Geron implies that they have significant influence over the...
Zacks
Geron (GERN) Wins FDA Approval for Blood Cancer Drug, Stock Up
Geron's (GERN) shares rise on approval of its first drug. The FDA approves imetelstat for the treatment of adult patients with lower-risk MDS with transfusion-dependent anemia.